4//SEC Filing
Roberts William T. 4
Accession 0001104659-23-040415
CIK 0001649904other
Filed
Mar 30, 8:00 PM ET
Accepted
Mar 31, 9:38 PM ET
Size
9.0 KB
Accession
0001104659-23-040415
Insider Transaction Report
Form 4
Roberts William T.
Chief Accounting Officer
Transactions
- Sale
Common Stock
2023-03-29$17.50/sh−912$15,960→ 7,872 total - Exercise/Conversion
Restricted Stock Units
2023-03-29−2,500→ 5,000 total→ Common Stock (2,500 underlying) - Exercise/Conversion
Common Stock
2023-03-29+2,500→ 8,784 total
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
- [F2]The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units.
- [F3]The restricted stock units vest or have vested as to 50% of the shares on each of March 29, 2024 and March 29, 2025. The restricted stock units have no expiration date.
Documents
Issuer
RHYTHM PHARMACEUTICALS, INC.
CIK 0001649904
Entity typeother
Related Parties
1- filerCIK 0001852360
Filing Metadata
- Form type
- 4
- Filed
- Mar 30, 8:00 PM ET
- Accepted
- Mar 31, 9:38 PM ET
- Size
- 9.0 KB